Tango Therapeutics, Inc. (NASDAQ: TNGX) reported Q1 EPS of ($0.32), $0.01 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Tango Therapeutics, Inc. (TNGX) click here.